Charles River Laboratories International, Inc.
CRL
$178.36
$2.441.39%
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -214.65% | -20.29% | -3.03% | -29.26% | -0.17% |
| Total Depreciation and Amortization | 15.14% | 11.83% | 10.83% | 10.75% | 3.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 480.45% | -39.14% | 0.57% | -6.93% | 2.35% |
| Change in Net Operating Assets | -210.44% | 2,997.53% | 77.84% | 47.69% | -32.52% |
| Cash from Operations | -27.87% | 22.56% | 30.66% | 18.75% | -5.88% |
| Capital Expenditure | 3.46% | 41.28% | 41.40% | 25.95% | 12.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.84% | 227.83% | -83.19% | 42.58% | 48.34% |
| Cash from Investing | 68.07% | 73.20% | 19.24% | 49.12% | -637.08% |
| Total Debt Issued | -76.36% | 359.78% | 393.10% | 56.30% | 188.31% |
| Total Debt Repaid | 44.89% | -54.14% | -335.05% | -85.91% | 21.43% |
| Issuance of Common Stock | -87.07% | -80.22% | -78.97% | 82.37% | -19.74% |
| Repurchase of Common Stock | 10.79% | -265,126.32% | -79.50% | 50.82% | 12.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.06% | -224.87% | -- | 18.55% | -179.28% |
| Cash from Financing | -161.41% | -27.43% | -300.00% | -27.32% | 149.63% |
| Foreign Exchange rate Adjustments | -205.70% | 224.50% | -1,950.31% | -601.92% | -14.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.11% | 170.98% | -138,085.09% | 267.23% | 163.93% |
